Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: A year in review: discussions in nuclear medicine. | Front Med (Lausanne) | 2024 | 38379559 | PubTator, text mining | PubMed |
| Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03. | Eur J Nucl Med Mol Imaging | 2024 | 38376806 | PubTator, text mining | PubMed |
| Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review. | Semin Nucl Med | 2024 | 38342656 | PubTator, text mining | PubMed |
| Molecularly Targeted Lanthanide Nanoparticles for Cancer Theranostic Applications. | Nanomaterials (Basel) | 2024 | 38334567 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes as a promising cell-free therapy for knee osteoarthritis. | Front Bioeng Biotechnol | 2024 | 38292826 | PubTator, text mining | PubMed |
| Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers. | Cancer Imaging | 2024 | 38279185 | PubTator, text mining | PubMed |
| Graphene Oxide Nanoparticles and Organoids: A Prospective Advanced Model for Pancreatic Cancer Research. | Int J Mol Sci | 2024 | 38256139 | PubTator, text mining | PubMed |
| Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023. | Theranostics | 2024 | 38250038 | PubTator, text mining | PubMed |
| Effective prognostic risk model with cuproptosis-related genes in laryngeal cancer. | Braz J Otorhinolaryngol | 2024 | 38228050 | PubTator, text mining | PubMed |
| Carrier systems of radiopharmaceuticals and the application in cancer therapy. | Cell Death Discov | 2024 | 38195680 | PubTator, text mining | PubMed |
| Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm clinical trial. | Theranostics | 2024 | 38169486 | PubTator, text mining | PubMed |
| Synergistic vesicle-vector systems for targeted delivery. | J Nanobiotechnology | 2024 | 38167116 | PubTator, text mining | PubMed |
| Gold Polymer Nanomaterials: A Promising Approach for Enhanced Biomolecular Imaging. | Nanotheranostics | 2024 | 38164503 | PubTator, text mining | PubMed |
| FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells. | Int J Oncol | 2024 | 38131188 | PubTator, text mining | PubMed |
| Distinctive mesenchymal-like neurofibroma stem cells shape NF1 clinical phenotypes controlled by BDNF microenvironment. | Transl Oncol | 2024 | 38042136 | PubTator, text mining | PubMed |
| Assessment of the bound conformation of bombesin to the BB1 and BB2 receptors. | Int J Biol Macromol | 2024 | 37956803 | PubTator, text mining | PubMed |
| The Balance Between the Therapeutic Efficacy and Safety of [177Lu]Lu-NeoB in a Preclinical Prostate Cancer Model. | Mol Imaging Biol | 2024 | 37640941 | PubTator, text mining | PubMed |
| GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway. | Hepatology | 2024 | 37409771 | PubTator, text mining | PubMed |
| Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT? | Semin Nucl Med | 2024 | 37394289 | PubTator, text mining | PubMed |
| Theranostics in breast cancer. | Front Nucl Med | 2023 | 39355052 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=8